Emergency Preparedness and Response
Public Workshop on Burkholderia
November 29-30, 2012
FDA White Oak Headquarters
10903 New Hampshire Ave
Silver Spring, MD, 20993
Day one: 8 a.m. - 5 p.m. EST
Day two: 8 a.m. - 12 p.m. EST
On Nov. 29-30, 2012, FDA’s Medical Countermeasures initiative (MCMi) is sponsoring a Public Workshop on Burkholderia (see also Federal Register notice) in collaboration with the:
- Defense Threat Reduction Agency;
- National Institutes of Health;
- Centers for Disease Control and Prevention;
- U.S. Army Medical Research Institute of Infectious Diseases;
- Biomedical Advanced Research and Development Authority;
- Chemical Biological Medical Systems Joint Project Management Office;
- U.S. Strategic Command Center for Combating Weapons of Mass Destruction; and
- Joint Science and Technology Office for Chemical and Biological Defense.
The workshop will present the latest information on melioidosis (caused by Burkholderia pseudomallei) and glanders (caused by Burkholderia mallei), building on previous meetings and identifying areas of research needed to advance animal model development and candidate medical countermeasures (MCMs) for approval, licensure, or clearance.
Suggested preparatory reading material for the workshop:
and glanders. Expert Rev Anti Infect Ther. 2010 Mar; 8(3): 325-38
for clinical, environmental or forensic detection applications. PLoS One. 2012; 7(5): e37723.
Epub 2012 May 18
melioidosis. PLoS One. 2012; 7(8): e43207. Epub 2012 Aug 15
human melioidosis. PLoS Pathog. 2008 Oct; 4(10): e1000178. Epub 2008 Oct 17
exploit biodefense vaccines for public health purposes.
PLoS Negl Trop Dis. 2012 Jan; 6(1): e1488. Epub 2012 Jan 31